The Role of p53, MDM2 and c-erb B-2 Oncoproteins, Epidermal Growth Factor Receptor and Proliferation Markers in the Prognosis of Urinary Bladder Cancer
- 31 December 1997
- journal article
- Published by Elsevier in Pathology - Research and Practice
- Vol. 193 (11-12) , 767-775
- https://doi.org/10.1016/s0344-0338(97)80055-6
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Expression of mdm-2 and p53 protein in transitional cell carcinomaUrological Research, 1995
- Oncogene Amplification in Urothelial Cancers With p53 Gene Mutation or MDM2 AmplificationJNCI Journal of the National Cancer Institute, 1994
- p53 mutations in human bladder cancer: Genotypic versus phenotypic patternsInternational Journal of Cancer, 1994
- Clinical significance of DNA ploidy and S-phase fraction and their relation to p53 protein, c-erbB-2 protein and HCG in operable muscle-invasive bladder cancerBritish Journal of Cancer, 1993
- Molecular Genetic Alterations of Chromosome 17 and p53 Nuclear Overexpression in Human Bladder CancerDiagnostic Molecular Pathology, 1993
- Immunocytochemical localization of c‐erbB‐2 protein in transitional cell carcinoma of the urinary bladderThe Journal of Pathology, 1993
- Monoclonal antibodies against recombinant parts of the Ki‐67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave‐processed formalin‐fixed paraffin sectionsThe Journal of Pathology, 1992
- Proliferation in human bladder carcinoma measured by Ki-67 antibody labelling: its potential clinical importanceBritish Journal of Cancer, 1991
- Amplification and over-expression of c-erbB-2 in transitional cell carcinoma of the urinary bladderBritish Journal of Cancer, 1991
- Evaluation of epidermal growth factor receptors in bladder tumoursBritish Journal of Cancer, 1987